These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8122313)

  • 21. Comparison of 5-hydroxytryptamine1A-mediated hyperpolarization in CA1 and CA3 hippocampal pyramidal cells.
    Beck SG; Choi KC; List TJ
    J Pharmacol Exp Ther; 1992 Oct; 263(1):350-9. PubMed ID: 1403796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo estimates of efficacy at 5-HT1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats.
    Koek W; Assié MB; Zernig G; France CP
    Psychopharmacology (Berl); 2000 May; 149(4):377-87. PubMed ID: 10867965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525.
    Lanfumey L; Haj-Dahmane S; Hamon M
    Eur J Pharmacol; 1993 Nov; 249(1):25-35. PubMed ID: 8282017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
    Hjorth S; Pettersson G
    Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-HT1A receptor full and partial agonists and 5-HT2C (but not 5-HT3) receptor antagonists increase rates of punished responding in rats.
    Cervo L; Samanin R
    Pharmacol Biochem Behav; 1995 Dec; 52(4):671-6. PubMed ID: 8587903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectively.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Gobert A; Widdowson P; Bervoets K; Brocco M; Peglion JL
    Eur J Pharmacol; 1993 Jan; 230(1):99-102. PubMed ID: 8381359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-HT1A receptor-mediated inhibition in the hippocampus of the alert rat--effects of repeated gepirone treatment.
    Manahan-Vaughan D; Anwyl R; Rowan MJ
    Eur J Pharmacol; 1994 Aug; 260(2-3):149-55. PubMed ID: 7988638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding thermodynamics of 5-HT1A receptor ligands.
    Dalpiaz A; Borea PA; Gessi S; Gilli G
    Eur J Pharmacol; 1996 Sep; 312(1):107-14. PubMed ID: 8891585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agonist occupation of serotonin1A receptors in the rat hippocampus prevents their inactivation by pertussis toxin.
    Hadrava V; Blier P; de Montigny C
    Neuroscience; 1994 Jul; 61(1):21-30. PubMed ID: 7969892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effects of novel 5-HT1A receptor ligands, LY293284, LY315712 and LY297996, on plus-maze anxiety in mice.
    Cao BJ; Rodgers RJ
    Psychopharmacology (Berl); 1998 Oct; 139(3):185-94. PubMed ID: 9784072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1,2,5-Thiadiazole derivatives are potent and selective ligands at human 5-HT1A receptors.
    Sabb AL; Vogel RL; Kelly MG; Palmer Y; Smith DL; Andree TH; Schechter LE
    Bioorg Med Chem Lett; 2001 Apr; 11(8):1069-71. PubMed ID: 11327592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BIMT 17, a 5-HT2A receptor antagonist and 5-HT1A receptor full agonist in rat cerebral cortex.
    Borsini F; Giraldo E; Monferini E; Antonini G; Parenti M; Bietti G; Donetti A
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):276-82. PubMed ID: 8584042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological characterisation of 5-HT receptors positively coupled to adenylyl cyclase in the rat hippocampus.
    Markstein R; Matsumoto M; Kohler C; Togashi H; Yoshioka M; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):454-9. PubMed ID: 10431755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 9-substituted 1,2,3,4-tetrahydro-beta-carbolin-1-ones, new 5-HT1A and 5-HT2A receptor ligands.
    Mokrosz MJ; Boksa J; Charakchieva-Minol S; Wesołowska A; Borycz J
    Pol J Pharmacol; 1999; 51(4):351-6. PubMed ID: 10540967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioural response to pharmacologic manipulation of serotonin receptors in the genetically dystonic hamster.
    Richter A; Löscher W
    Pharmacol Biochem Behav; 1995 Dec; 52(4):655-65. PubMed ID: 8587901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-HT1A receptor agonist properties of the antipsychotic, nemonapride: comparison with bromerguride and clozapine.
    Assié MB; Cosi C; Koek W
    Eur J Pharmacol; 1997 Sep; 334(2-3):141-7. PubMed ID: 9369342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of serotonergic agonists with varying efficacy at the 5-HT(1A) receptor on core body temperature: modification by the selective 5-HT(1A) receptor antagonist WAY 100635.
    Cryan JF; Kelliher P; Kelly JP; Leonard BE
    J Psychopharmacol; 1999; 13(3):278-83. PubMed ID: 10512084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of 5-HT1A receptor-mediated [35S]GTPgammaS binding in rat hippocampal membranes.
    Alper RH; Nelson DL
    Eur J Pharmacol; 1998 Feb; 343(2-3):303-12. PubMed ID: 9570480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A model of the serotonin 5-HT1A receptor: agonist and antagonist binding sites.
    Kuipers W; Van Wijngaarden I; Ijzerman AP
    Drug Des Discov; 1994 Apr; 11(3):231-49. PubMed ID: 7548638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.